Axithra is a spin-off from Ghent University and imec, developing a platform to quickly and accurately measure and monitor drug concentrations in blood, paving the way for treatments tailored to the specific needs of each individual, at any given time. The first application is focusing on personalizing beta-lactam antibiotics treatments in the intensive care unit. The company’s platform is based on proprietary optical and photonics technology and will allow physicians to optimize patient care by enabling personalized treatments.
| Website | https://axithra.com |
| Employees | 19 (8 on RocketReach) |
| Founded | 2023 |
| Industry | Medical Equipment Manufacturing |
| Keywords | Drug Monitoring, Pharmaceutical Technology, Blood Analysis, Therapeutic Drug Monitoring, Precision Medicine, Patient Specific Treatment, Biomedical Engineering, Real Time Monitoring, Pharmacokinetics, Drug Development, In Vivo Diagnostics, Point Of Care Diagnostics, Clinical Diagnostics, Healthcare Technology, Lab On A Chip, Biomarker Detection, Biosensors, Medical Devices |
| Competitors | Palantir Technologies, Splunk, DataRobot, Tableau, Qlik, Kalypso: A Rockwell Automation Business, Genscape, Cogo Labs, Civitas Health Services, Inc., Fathom.ai +42 more (view full list) |
Looking for a particular Axithra employee's phone or email?
Axithra Questions
Lars Kongsbak is the CEO of Axithra.
8 people are employed at Axithra.
Top Axithra Employees
-
25+
-
Leander van Neste
Co-Founder and CEO at Axithra
Hoegaarden, BE2 -
2
-
13
-
Jorik W.
R and D Engineer at Axithra
Leuven, Flanders, BE1
